Search
for
Sort by
Research 391–420 of 450
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Management of psychiatric disorders with HIV and dermatological disorders
- Persistent scurvy after vitamin C supplementation in a high-risk patient: a case report
- Under‐Explored Species, Breeds and Cell Types With Potential for Cultivated Meat Production
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology
- Management of Alopecia and Onychomycosis in a Lupus Patient
- Stable isotope analyses of carbon and nitrogen in hair keratin of suspected man-eating wolves from 1880s
- Skin Disease in Korean Human Immunodeficiency Virus Patient
- Determination of zinc levels in commercially available vegetables in Kaduna, Nigeria and its environs
- Prophylactic Amotosalen-Treated Donor T-Cells Prevent Late CMV Infection in Allogeneic Bone Marrow Transplantation.
- HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The Pathobiology of Skin Aging
- Prostate Cancer Early Detection, Version 2.2015
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Anticancer agents against malaria: time to revisit?
- Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Engineering a bacterial polysaccharide-based metal–organic framework-enhanced bioactive 3D hydrogel for accelerated full-thickness wound healing
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- A Global Survey of Ethnic Indian Women Living with Polycystic Ovary Syndrome: Co-Morbidities, Concerns, Diagnosis Experiences, Quality of Life, and Use of Treatment Methods
- A Systematic Review of Antiaging Effects of 23 Traditional Chinese Medicines
- Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases